IP Library Patent Application 12739195
Patent Application
App. No. 12/739,195

11B-FLUORO-3-ACETOXYESTRA-3,5-DIEN-17-ONE AND METHOD FOR THE PRODUCTION THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/739,195
Abstract

The present invention relates to 11β-fluoro-3-acetoxyestra-3,5-dien-17-one as a suitable intermediate in the preparation of 11-fluoro-substituted steroids and to the process for preparation thereof. For this purpose, 11α-hydroxyestra-4-ene-3,17-dione is reacted with 1 to 3 equivalents of n-nonafluorobutanesulfonyl fluoride and 3 to 5 equivalents of diazabicycloundecene (DBU) at −40 to −20° C. in an organic aprotic solvent and, after an aqueous workup, reacted with 5 to 10 equivalents of acetic anhydride and 0.01 to 1 equivalent of a strong acid. The desired product precipitates spontaneously out of the reaction solution and is obtained in a very high purity by filtration. The process is notable for the very high yield, avoidance of a chromatographic purification of the product, a reduced proportion of wastes and significantly increased process throughput. The process according to the invention is therefore especially suitable for preparing 11β-fluoro-3-acetoxyestra-3,5-dien-17-one on a large industrial scale.

Claims (6)

1 . 11β-Fluoro-3-acetoxyestra-3,5-dien-17-one.

2 . A process for preparing 11β-fluoro-3-acetoxyestra-3,5-dien-17-one, characterized in that 11α-hydroxyestra-4-ene-3,17-dione is allowed to react with 1 to 3 equivalents of n-nonafluorobutanesulfonyl fluoride and 3 to 5 equivalents of diazabicycloundecene (DBU) at −40 to −20° C. in an organic aprotic solvent and, after an aqueous intermediate workup, reacted with 5 to 10 equivalents of acetylating agent in the presence of 0.01 to 1 equivalent of a strong acid, and the precipitated product is obtained by filtering the reaction mixture.

3 . The process for preparing 11β-fluoro-3-acetoxyestra-3,5-dien-17-one as claimed in claim 2 , characterized in that more than 3 equivalents of DBU are used.

4 . The process for preparing 11β-fluoro-3-acetoxyestra-3,5-dien-17-one as claimed in claim 2 , characterized in that ethyl acetate is used as the solvent.

5 . The process for preparing 11β-fluoro-3-acetoxyestra-3,5-dien-17-one as claimed in claim 2 , characterized in that reaction is effected with acetic anhydride as the acetylating agent.

6 . The process for preparing 11β-fluoro-3-acetoxyestra-3,5-dien-17-one as claimed in claim 2 , characterized in that reaction is effected with p-tolulenesulfonic acid (p-TsOH) as the strong acid.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030516/0512 →
CHANGE OF NAME Recorded Apr 11, 2013
From: BAYER SCHERING PHARMA AG
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030199/0001 →
CHANGE OF NAME Recorded Nov 11, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029277/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2010
From: PETROV, ORLIN; SCHNEIDER, MATTHIAS; BOHLMANN, ROLF; VETTEL, STEPHAN
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 024962/0025 →